Answers are grounded in this paper and cite their sources.
To evaluate the feasibility of patient-led self-monitoring of plasma urate and dose escalation of allopurinol, in primary care, from the perspectives of patients and healthcare personnel. Management of patients with gout remains suboptimal, improvement can involve a self-monitoring procedure. There are no prior studies testing the feasibility of self-monitoring of urate during titration of allopurinol supported by nurses in primary care. A mixed-methods study. Interviews with general practitioners and patients in Swedish primary care. Quantitative data was collected from patients using quality of life and person-centeredness questionnaires, and from personnel about perceived acceptability, relevance and feasibility of the procedure tested. Electronic health records were reviewed. The measure-report-titrate procedure and its introduction was considered acceptable, appropriate and feasible by all participants. Challenges identified included practical difficulties in using the urate meter and limited confidence in the accuracy of the urate measures. All patients completed the procedure and achieved their target urate level. Personnel persisted requiring necessary conditions for a successful implementation. Patients and personnel reported increased awareness and knowledge, ease of anxiety about disease progression and an experience of receiving individualized care. Self-monitoring of urate during allopurinol titration may serve as an alternative to regular laboratory testing. The measure-report-titrate procedure appeared to enhance patients’ knowledge of treatment and increase engagement in their care. These findings will inform the implementation of nurse-led gout management in primary care.
No takes yet. Share an insight, caveat, or question.
Sedelius et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: